Santalis Pharmaceuticals Signs Exclusive License Agreement With Global Pharmaceutical Company To Commercialize OTC Dermatology Products
2/26/2014 8:59:10 AM
SAN ANTONIO--(BUSINESS WIRE)--Santalis Pharmaceuticals Inc., a joint venture with TFS Corporation Ltd., of Australia (ASX: TFC) is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of a number of over-the-counter (OTC) dermatology products containing TFS’ sustainably cultivated, pharmaceutical-grade East Indian Sandalwood Oil (EISO).
Help employers find you! Check out all the jobs and post your resume.
comments powered by